Avanos Medical AVNS Corporate and other — Net Sales
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Avanos Medical in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Avanos Medical's corporate and other — net sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Avanos Medical's corporate and other — net sales?
- Avanos Medical (AVNS) reported corporate and other — net sales of $1.9M in Q1 2026.
- How has Avanos Medical's corporate and other — net sales changed year-over-year?
- Avanos Medical's corporate and other — net sales decreased by 81.4% year-over-year, from $10.2M to $1.9M.
- What is the long-term trend for Avanos Medical's corporate and other — net sales?
- Over 2 years (2023 to 2025), Avanos Medical's corporate and other — net sales has grown at a -36.0% compound annual growth rate (CAGR), from $74.4M to $30.5M.
- What does corporate and other — net sales mean?
- This metric represents the revenue generated by business activities that are not directly attributable to the company's primary reportable operating segments. It typically captures income from peripheral services, legacy product lines, or administrative functions that do not align with the core medical device franchises. Tracking this figure helps investors understand the scale of non-core operations and the extent to which the company is consolidating its focus on primary growth areas.